Long-standing malignant pancreatic carcinoid treated with octreotide.
Rev Esp Enferm Dig
; 102(11): 662-6, 2010 Nov.
Article
in En
| MEDLINE
| ID: mdl-21142389
ABSTRACT
A male presented with a metastatic, plasma serotonin-secreting (high 5-HIAA in urine), malignant pancreatic carcinoid with a carcinoid-like syndrome, and was assessed using ultrasounds (US), computerized tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography (EUS) and Octreoscan; he sequentially received chemotherapy, interferon and octreotide, with long-term, 12-year survival after diagnosis. Given this unusual case, the second reported in our country, the overall literature is reviewed.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Carcinoid Tumor
/
Octreotide
/
Antineoplastic Agents, Hormonal
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Rev Esp Enferm Dig
Journal subject:
GASTROENTEROLOGIA
Year:
2010
Document type:
Article
Affiliation country:
Spain